{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:38:46Z","timestamp":1794433126610,"version":"4.9.1"},"reference-count":73,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to quantitatively analyse nortriptyline\u2019s analgesic potency, safety and tolerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>The systematic search was conducted in Scopus, Web of Science and PubMed in February 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                    <jats:p>Clinical trials evaluating the efficacy of nortriptyline in reducing pain scores (open-label studies and comparisons of nortriptyline with placebo or other analgesics) in different pain types were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>The data extraction procedure and the screening phases were carried out based on predetermined eligibility criteria. To pool the data, the standardised mean difference (SMD) and standardised mean change (SMC) methods, along with random-effect and fixed-effect meta-analysis, were used. The risk of bias was assessed using the Cochrane Collaboration method, and the Grading of Recommendations Assessment, Development and Evaluation criteria were used to measure the certainty of the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>14 of the initial 648 studies were eventually imported. Nortriptyline was reported to significantly reduce pain severity in chronic low back pain, painful symptoms in major depressive disorder, neuropathy, chronic pelvic pain and neuropathic corneal pain. However, it was not superior to placebo in fibromyalgia and knee osteoarthritis. In comparison to placebo and various alternative analgesics, the pooled SMD for lowering pain scores was 0.43 (0.23\u20130.64) and \u22120.18 (\u22120.39 to 0.03), respectively. In the pretreatment and post-treatment analyses, the pooled SMC was \u22121.20 (\u22121.48 to \u20130.93). Although constipation and xerostomia were the most commonly reported side effects, all references indicated that the adverse events were well tolerated at the administered dosages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While nortriptyline is effective in some chronic pains, such as neuropathies, it lacks efficacy in some other chronic pains, such as fibromyalgia and osteoarthritis. Nortriptyline is well tolerated when administered in doses intended for its analgesic effects. Moreover, several studies suggested that the analgesic effects of nortriptyline are comparable to those of amitriptyline and gabapentin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-085438","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:31:37Z","timestamp":1723163497000},"page":"e085438","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Quantitative analysis of nortriptyline\u2019s analgesic properties: a comparative systematic review and meta-analysis"],"prefix":"10.1136","volume":"14","author":[{"given":"Soroush","family":"Hashemzadeh","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Islamic Azad University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mortazavi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tehran Islamic Azad University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7875-7351","authenticated-orcid":false,"given":"Ramin","family":"Abdi Dezfouli","sequence":"additional","affiliation":[{"name":"Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2025121222212832000_14.8.e085438.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.04.007"},{"key":"2025121222212832000_14.8.e085438.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.04.004"},{"key":"2025121222212832000_14.8.e085438.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.04.010."},{"key":"2025121222212832000_14.8.e085438.4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/bean.2003.0267","article-title":"Opioid and non-opioid analgesics","volume":"17","author":"Schug","year":"2003","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2025121222212832000_14.8.e085438.5","first-page":"S233","article-title":"Corticosteroids: review of the history, the effectiveness, and adverse effects in the treatment of joint pain","volume":"24","author":"Stone","year":"2021","journal-title":"Pain Physician"},{"key":"2025121222212832000_14.8.e085438.6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/NOR.0000000000000595","article-title":"Corticosteroids","volume":"38","author":"Kapugi","year":"2019","journal-title":"Orthop Nurs"},{"key":"2025121222212832000_14.8.e085438.7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/bmj.n104","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain","volume":"372","author":"Machado","year":"2021","journal-title":"BMJ"},{"key":"2025121222212832000_14.8.e085438.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-016-0591-7","article-title":"NSAIDs in the treatment of postoperative pain","volume":"20","author":"Gupta","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"2025121222212832000_14.8.e085438.9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.580289","article-title":"Analgesic effect of acetaminophen: a review of known and novel mechanisms of action","volume":"11","author":"Ohashi","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025121222212832000_14.8.e085438.10","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S1928"},{"key":"2025121222212832000_14.8.e085438.11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","article-title":"Expanding role of NMDA receptor antagonists in the management of pain","volume":"33","author":"Kreutzwiser","year":"2019","journal-title":"CNS Drugs"},{"key":"2025121222212832000_14.8.e085438.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03047-y"},{"key":"2025121222212832000_14.8.e085438.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00629-2"},{"key":"2025121222212832000_14.8.e085438.14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/cpt.1701","article-title":"Acetaminophen-induced liver damage in hepatic steatosis","volume":"107","author":"Garc\u00eda-Rom\u00e1n","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"2025121222212832000_14.8.e085438.15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.etp.2007.10.003","article-title":"Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system","volume":"59","author":"Olaleye","year":"2008","journal-title":"Exp Toxicol Pathol"},{"key":"2025121222212832000_14.8.e085438.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0"},{"key":"2025121222212832000_14.8.e085438.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.06.019"},{"key":"2025121222212832000_14.8.e085438.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.02999.x"},{"key":"2025121222212832000_14.8.e085438.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.033"},{"key":"2025121222212832000_14.8.e085438.20","unstructured":"Moraczewski J , Aedma KK . Tricyclic antidepressants. In: StatPearls. StatPearls Publishing, 2022."},{"key":"2025121222212832000_14.8.e085438.21","first-page":"123","article-title":"Mechanism of action of antidepressants","volume":"36 Suppl 2","author":"Artigas","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"2025121222212832000_14.8.e085438.22","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.86a.19005"},{"key":"2025121222212832000_14.8.e085438.23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18860\/jip.v4i2.8217","article-title":"Tricyclic antidepressants in chronic low back pain\u202f: a review","volume":"4","author":"Ilmanita","year":"2019","journal-title":"J Islamic Pharm"},{"key":"2025121222212832000_14.8.e085438.24","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v13i4.45539","article-title":"Tricyclic antidepressants: an update","volume":"13","author":"Balda\u00e7ara","year":"2024","journal-title":"RSD"},{"key":"2025121222212832000_14.8.e085438.25","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010394852"},{"key":"2025121222212832000_14.8.e085438.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2025121222212832000_14.8.e085438.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001419","article-title":"PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts","volume":"10","author":"Beller","year":"2013","journal-title":"PLoS Med"},{"key":"2025121222212832000_14.8.e085438.28","doi-asserted-by":"crossref","unstructured":"Borenstein M , Hedges LV , Higgins JPT . Introduction to meta-analysis. John Wiley & Sons, 2021.","DOI":"10.1002\/9781119558378"},{"key":"2025121222212832000_14.8.e085438.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2025121222212832000_14.8.e085438.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025121222212832000_14.8.e085438.31","first-page":"697","article-title":"A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures","volume":"19","author":"Heymann","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2025121222212832000_14.8.e085438.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00064-5"},{"key":"2025121222212832000_14.8.e085438.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.10.029"},{"key":"2025121222212832000_14.8.e085438.34","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2020.0797"},{"key":"2025121222212832000_14.8.e085438.35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP trial","volume":"44","author":"Chandra","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025121222212832000_14.8.e085438.36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology (ECronicon)"},{"key":"2025121222212832000_14.8.e085438.37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2190\/EXRP-J206-CBWT-UTFK","article-title":"An open trial of nortriptyline in women with chronic pelvic pain","volume":"21","author":"Walker","year":"1991","journal-title":"Int J Psychiatry Med"},{"key":"2025121222212832000_14.8.e085438.38","first-page":"29","article-title":"Analgesic effect of duloxetine compared to nortryptiline in patients with painful neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Bayani","year":"2021","journal-title":"Casp J Intern Med"},{"key":"2025121222212832000_14.8.e085438.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01745.x"},{"key":"2025121222212832000_14.8.e085438.40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.genhosppsych.2014.10.005","article-title":"Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression","volume":"37","author":"Jaracz","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"2025121222212832000_14.8.e085438.41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jtos.2020.08.006","article-title":"Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain","volume":"18","author":"Ozmen","year":"2020","journal-title":"Ocul Surf"},{"key":"2025121222212832000_14.8.e085438.42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/ane.12169","article-title":"Equivalency of tricyclic antidepressants in open-label neuropathic pain study","volume":"129","author":"Liu","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"2025121222212832000_14.8.e085438.43","doi-asserted-by":"crossref","unstructured":"Zakerkish M , Amiri F , Majdi Nasab N , et al . Comparative efficacy of duloxetine versus nortriptyline in patients with diabetic peripheral neuropathic pain: a double blind randomized controlled trial. Iran Red Crescent Med J 2017;19. doi:10.5812\/ircmj.59995","DOI":"10.5812\/ircmj.59995"},{"key":"2025121222212832000_14.8.e085438.44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0043-122077","article-title":"Is venlafaxine more effective than escitalopram and nortriptyline in the management of painful symptoms in patients with major depression?","volume":"51","author":"Jaracz","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"2025121222212832000_14.8.e085438.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.08.013"},{"key":"2025121222212832000_14.8.e085438.46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/87551225221139699","article-title":"Tricyclic antidepressants in nociceptive and neuropathic pain: a review of their analgesic properties in combination with opioids","volume":"39","author":"Reinert","year":"2023","journal-title":"J Pharm Technol"},{"key":"2025121222212832000_14.8.e085438.47","doi-asserted-by":"publisher","DOI":"10.1177\/089198879100400409"},{"key":"2025121222212832000_14.8.e085438.48","first-page":"58","article-title":"Tricyclic side effects without tricyclics in depression","volume":"16","author":"Mathew","year":"1980","journal-title":"Psychopharmacol Bull"},{"key":"2025121222212832000_14.8.e085438.49","first-page":"40","article-title":"Antimuscarinic and other receptor-blocking properties of antidepressants","volume":"58","author":"Richelson","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"2025121222212832000_14.8.e085438.50","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9"},{"key":"2025121222212832000_14.8.e085438.51","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00307","article-title":"Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis","volume":"8","author":"Riediger","year":"2017","journal-title":"Front Neurol"},{"key":"2025121222212832000_14.8.e085438.52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707253"},{"key":"2025121222212832000_14.8.e085438.53","unstructured":"Merwar G , Gibbons JR , Hosseini SA , et al . Nortriptyline. 2018."},{"key":"2025121222212832000_14.8.e085438.54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5530\/ijcep.2018.5.3.3","article-title":"Antinociceptive activity of nortriptyline through the adrenergic system - an in vivo study in mice","volume":"5","author":"Tavakoli","year":"2019","journal-title":"IJCEP"},{"key":"2025121222212832000_14.8.e085438.55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000370244","article-title":"Antinociceptive synergism of gabapentin and nortriptyline in mice with partial sciatic nerve ligation","volume":"95","author":"Miranda","year":"2015","journal-title":"Pharmacology"},{"key":"2025121222212832000_14.8.e085438.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-0102(97)00072-2"},{"key":"2025121222212832000_14.8.e085438.57","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/jm900143u","article-title":"Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity","volume":"52","author":"Rephaeli","year":"2009","journal-title":"J Med Chem"},{"key":"2025121222212832000_14.8.e085438.58","doi-asserted-by":"publisher","DOI":"10.1017\/S146114570500547X"},{"key":"2025121222212832000_14.8.e085438.59","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2025121222212832000_14.8.e085438.60","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350715"},{"key":"2025121222212832000_14.8.e085438.61","first-page":"21","article-title":"Antidepressants as analgesics: an overview of central and peripheral mechanisms of action","volume":"26","author":"Sawynok","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"2025121222212832000_14.8.e085438.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.10.001"},{"key":"2025121222212832000_14.8.e085438.63","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(69)90113-7"},{"key":"2025121222212832000_14.8.e085438.64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for neuropathic pain","volume":"18","author":"Obata","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025121222212832000_14.8.e085438.65","doi-asserted-by":"crossref","first-page":"113848","DOI":"10.1016\/j.physbeh.2022.113848","article-title":"Blocking the dopaminergic receptors in the hippocampal dentate gyrus reduced the stress-induced analgesia in persistent inflammatory pain in the rat","volume":"253","author":"Merdasi","year":"2022","journal-title":"Physiol Behav"},{"key":"2025121222212832000_14.8.e085438.66","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200307000-00030"},{"key":"2025121222212832000_14.8.e085438.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.08.008"},{"key":"2025121222212832000_14.8.e085438.68","doi-asserted-by":"crossref","first-page":"114307","DOI":"10.1016\/j.bbr.2023.114307","article-title":"Restraint stress induced the antinociceptive responses via the dopamine receptors within the hippocampal CA1 area in animal model of persistent inflammatory pain","volume":"443","author":"Dezfouli","year":"2023","journal-title":"Behav Brain Res"},{"key":"2025121222212832000_14.8.e085438.69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"2025121222212832000_14.8.e085438.70","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/FBP.0000000000000697","article-title":"The modulatory role of dopamine receptors within the hippocampal cornu ammonis area 1 in stress-induced analgesia in an animal model of persistent inflammatory pain","volume":"33","author":"Abdi Dezfouli","year":"2022","journal-title":"Behav Pharmacol"},{"key":"2025121222212832000_14.8.e085438.71","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199608060-00008"},{"key":"2025121222212832000_14.8.e085438.72","article-title":"Desipramine for neuropathic pain in adults","volume":"2014","author":"Hearn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121222212832000_14.8.e085438.73","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.6.621.34748"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-085438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:21:42Z","timestamp":1765606902000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-085438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":73,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,8]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjopen-2024-085438"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085438","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085438.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}